Eugena Stamuli is a Health Economist (MSc, University of Sheffield, UK) with first degree in Pharmacy (BSc, National University of Athens, Greece). She has over 15 years of combined experience in consultancy and academic environment. The remit of her work is on Health Technology Assessment (HTA) in reimbursement decisions. Her areas of expertise include cost-effectiveness modelling/early modelling for HTA, design and conduct of economic evaluations alongside clinical trials, discrete choice experiments (DCEs) and patient preferences, patient reported outcomes (PROs), utility elicitation and evidence review & synthesis. She has conducted numerous primary studies and analyses in various disease areas. Eugena holds a Visiting Research Fellowship position with University of York, UK, where she worked for nearly 10 years as an academic researcher, prior to embarking on independent consulting services.